GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Gubra AS (OCSE:GUBRA) » Definitions » Receivables Turnover

Gubra AS (OCSE:GUBRA) Receivables Turnover : 2.67 (As of Dec. 2023)


View and export this data going back to 2023. Start your Free Trial

What is Gubra AS Receivables Turnover?

The Receivables Turnover ratio measures the number of times a company collects its average accounts receivable balance. It is calculated as Revenue divided by average Accounts Receivable. An efficient company has a higher accounts receivable turnover ratio while an inefficient company has a lower ratio. Gubra AS's Revenue for the six months ended in Dec. 2023 was kr103.2 Mil. Gubra AS's average Accounts Receivable for the six months ended in Dec. 2023 was kr38.7 Mil. Hence, Gubra AS's Receivables Turnover for the six months ended in Dec. 2023 was 2.67.


Gubra AS Receivables Turnover Historical Data

The historical data trend for Gubra AS's Receivables Turnover can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Gubra AS Receivables Turnover Chart

Gubra AS Annual Data
Trend Dec19 Dec20 Dec21 Dec22 Dec23
Receivables Turnover
- 4.07 4.08 3.32 4.61

Gubra AS Semi-Annual Data
Dec20 Dec21 Jun22 Dec22 Jun23 Dec23
Receivables Turnover Get a 7-Day Free Trial - 1.16 2.82 3.37 2.67

Competitive Comparison of Gubra AS's Receivables Turnover

For the Biotechnology subindustry, Gubra AS's Receivables Turnover, along with its competitors' market caps and Receivables Turnover data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Gubra AS's Receivables Turnover Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Gubra AS's Receivables Turnover distribution charts can be found below:

* The bar in red indicates where Gubra AS's Receivables Turnover falls into.



Gubra AS Receivables Turnover Calculation

Receivables Turnover measures the number of times a company collects its average accounts receivable balance.

Gubra AS's Receivables Turnover for the fiscal year that ended in Dec. 2023 is calculated as

Receivables Turnover (A: Dec. 2023 )
=Revenue / Average Total Inventories
=Revenue (A: Dec. 2023 ) / ((Accounts Receivable (A: Dec. 2022 ) + Accounts Receivable (A: Dec. 2023 )) / count )
=205.005 / ((36.093 + 52.912) / 2 )
=205.005 / 44.5025
=4.61

Gubra AS's Receivables Turnover for the quarter that ended in Dec. 2023 is calculated as

Receivables Turnover (Q: Dec. 2023 )
=Revenue / Average Total Inventories
=Revenue (Q: Dec. 2023 ) / ((Accounts Receivable (Q: Jun. 2023 ) + Accounts Receivable (Q: Dec. 2023 )) / count )
=103.188 / ((24.389 + 52.912) / 2 )
=103.188 / 38.6505
=2.67

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Gubra AS  (OCSE:GUBRA) Receivables Turnover Explanation

An efficient company has a higher accounts receivable turnover ratio while an inefficient company has a lower ratio. This metric is commonly used to compare companies within the same industry to check whether they are on par with their competitors.


Gubra AS Receivables Turnover Related Terms

Thank you for viewing the detailed overview of Gubra AS's Receivables Turnover provided by GuruFocus.com. Please click on the following links to see related term pages.


Gubra AS (OCSE:GUBRA) Business Description

Traded in Other Exchanges
Address
Hørsholm Kongevej 11B, Hørsholm, DNK, 2970
Gubra AS is a specialized preclinical CRO and biotech company focused on peptide-based drug discovery within metabolic and fibrotic diseases.

Gubra AS (OCSE:GUBRA) Headlines

No Headlines